FGFBP2: A Potential Drug Target for Various Tissues (G83888)

Target Name: FGFBP2

NCBI ID: G83888

FGFBP2

FGFBP2: A Potential Drug Target for Various Tissues

Fibroblast growth factor binding protein 2 (FGFBP2) is a protein that is expressed in various tissues throughout the body, including the skin, hair, nails, and bones. It is a member of the FGF family of proteins, which are known for their role in cell proliferation and growth. FGFBP2 has been shown to play a role in the regulation of cellular processes such as cell division, migration, and invasion, and is therefore considered a potential drug target (or biomarker).

The expression levels of FGFBP2 vary among different cell types. In adult tissues, FGFBP2 is mainly expressed in epidermal cells and sweat gland cells, while it is lower in hair follicle cells and nails. In some tumors, FGFBP2 expression levels are also increased. These differences make FGFBP2 a good drug target because the expression levels of FGFBP2 are different in different tissues, so different types of diseases can be treated by regulating the expression levels of FGFBP2.

The role of FGFBP2 in cell proliferation and growth is achieved by binding to FGF proteins. FGF protein is a serine protein kinase that can activate growth factor signaling pathways in cells. These signaling pathways include EGFR/MAPK, FGFR/MAPK and JAK/STAT signaling pathways. These signaling pathways play an important role in cell proliferation, growth and differentiation, and FGFBP2 is an important regulator of them.

Studies have shown that the expression level of FGFBP2 is closely related to the progression and treatment response of various cancers. For example, the expression level of FGFBP2 is closely related to the progression and treatment response of skin cancer, breast cancer and lung cancer. In addition, the expression level of FGFBP2 is also related to the invasion and metastasis ability of tumors. Therefore, studying FGFBP2 as a drug target or biomarker has important clinical significance.

Since FGFBP2 is a widely expressed protein, the best way to study FGFBP2 is to use small molecule compounds for screening. A series of compounds related to FGFBP2 have been discovered, including some traditional Chinese medicine and plant extracts. These compounds can regulate the expression level of FGFBP2 and thereby exert their pharmacological effects.

In addition, some studies have also shown that there is an interaction between FGFBP2 and its partner proteins (also called ligands). These interactions can affect the ligand binding and signaling of FGFBP2, thereby affecting its function. Therefore, it is also of great significance to study the interaction between FGFBP2 and its partner proteins.

FGFBP2 has important clinical significance as a drug target or biomarker. It can be used as a new target for the treatment of various tumors, especially skin cancer, breast cancer and lung cancer. It can also be used to detect tumor progression and treatment response.

Protein Name: Fibroblast Growth Factor Binding Protein 2

The "FGFBP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FGFBP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets